Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression (2016)
- Authors:
- Luizon, Marcelo R. - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
- Caldeira dias, Mayara - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
- Deffune, Elenice - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
- Fernandes, Karla S.
- Cavalli, Ricardo de Carvalho
- Tanus-Santos, José Eduardo
- Sandrim, Valéria Cristina - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
- USP affiliated authors: CAVALLI, RICARDO DE CARVALHO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.2217/pgs-2016-0033
- Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR); ENDOTÉLIO VASCULAR; EXPRESSÃO GÊNICA; CÉLULAS ENDOTELIAIS; PLASMA; PRÉ-ECLÂMPSIA
- Keywords: Antihypertensive drugs; Gene expression; Human umbilical vein endothelial cells; Hydralazine; Nifedipine; Pathway analysis; PCR array; Pharmacogenomics; Pre-eclampsia
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Pharmacogenomics
- ISSN: 1462-2416
- Volume/Número/Paginação/Ano: v. 17, n. 10, p. 1121-1127, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LUIZON, Marcelo R. et al. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression. Pharmacogenomics, v. 17, n. 10, p. 1121-1127, 2016Tradução . . Disponível em: https://doi.org/10.2217/pgs-2016-0033. Acesso em: 04 jun. 2024. -
APA
Luizon, M. R., Caldeira dias, M., Deffune, E., Fernandes, K. S., Cavalli, R. de C., Tanus-Santos, J. E., & Sandrim, V. C. (2016). Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression. Pharmacogenomics, 17( 10), 1121-1127. doi:10.2217/pgs-2016-0033 -
NLM
Luizon MR, Caldeira dias M, Deffune E, Fernandes KS, Cavalli R de C, Tanus-Santos JE, Sandrim VC. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression [Internet]. Pharmacogenomics. 2016 ; 17( 10): 1121-1127.[citado 2024 jun. 04 ] Available from: https://doi.org/10.2217/pgs-2016-0033 -
Vancouver
Luizon MR, Caldeira dias M, Deffune E, Fernandes KS, Cavalli R de C, Tanus-Santos JE, Sandrim VC. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression [Internet]. Pharmacogenomics. 2016 ; 17( 10): 1121-1127.[citado 2024 jun. 04 ] Available from: https://doi.org/10.2217/pgs-2016-0033 - Increased circulating cell-free hemoglobin levels reduce nitric biovailability in preeclampsia
- Plasma levels of increased miR-195-5p correlates with the sFLT-1 levels in preeclampsia
- Plasma from pre-eclamptic patients induces the expression of the anti-angiogenic miR-195-5p in endothelial cells
- Correlations among plasma Visfatin/NAMPT, nitrite and sFLT-1 levels, and gene interactions in the Visfatin/NAMPT pathway: role on pharmacogenetics of preeclampsia
- NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia
- Elevation of circulating cell-free DNA levels inplasma of women with preeclampsia and gestational hypertension
- Relationship between adiponectin and nitrite in healthy and preeclampsia pregnancies
- Antihypertensive therapy in preeclampsia is not modulated by VEGF polymorphisms
- eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension
- Aldosterone synthase gene polymorphism is not associated with gestational hypertension or preeclampsia. [carta]
Informações sobre o DOI: 10.2217/pgs-2016-0033 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
